WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹214 Cr | ₹320 Cr | ₹360 Cr | ₹355 Cr | ₹311 Cr |
What is the latest Total Current Liabilities ratio of WANBURY ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹214 Cr |
Mar2023 | ₹320 Cr |
Mar2022 | ₹360 Cr |
Mar2021 | ₹355 Cr |
Mar2020 | ₹311 Cr |
How is Total Current Liabilities of WANBURY Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹214 Cr | -33.10 | |
Mar2023 | ₹320 Cr | -11.05 | |
Mar2022 | ₹360 Cr | 1.24 | |
Mar2021 | ₹355 Cr | 14.25 | |
Mar2020 | ₹311 Cr | - |
Compare Total Current Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹709.5 Cr | -10% | -26% | 51.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,692.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,215.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹115,000.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,616.4 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,841.4 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -10% |
-26% |
51.6% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses